TReatment for ImmUne Mediated PathopHysiology

Clinical trial NCT04862221 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04862221
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Liver Failure Fulminant Hepatic Failure Hepatic Encephalopathy Acute Liver Injury Immune Dysregulation

Start date: 2022-02-09
Primary completion: 2026-08-03
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.